Carrillo, MD, discussed the background and findings from a study comparing patients who underwent thymectomy and nephrectomy.

In an in-person Community Case Forum event in partnership with the North Carolina Oncology Association and South Carolina ...

A study offers promising news for young women with early-stage breast cancer who want to have children after treatment, ...

Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the specific patient subgroups for whom autologous transplant remains the best course of action for.

A study has shown artificial intelligence virtual navigation to be a promising tool to improve colonoscopy completion rates, ...

During a Case-Based Roundtable® event, Sairah Ahmed, MD, discussed how the burgeoning use of chimeric antigen receptor T-cell ...

Rahul Banerjee, MD, FACP, physician-researcher at Fred Hutch Cancer Center in Seattle, WA, discusses the potential links ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

ODAC meeting discussed FDARA's impact on pediatric cancer drug development, emphasizing international collaboration and early ...

In separate live virtual events, James K. McCloskey II, MD, and Bart L. Scott, MD, polled participants on disease symptoms and bridging therapy options for a patient with primary myelofibrosis (PMF).

Jose Lutzky, MD, discusses the innovative tumor-inflitrating lymphocyte therapy for the treatment of relapsed or refractory melanoma.

In an interview with Targeted Oncology, Joe Leach, MD, highlighted the current state and future prospects of treating ...